Cytotoxic Chemotherapy for Pancreatic Cancer

This publication has 73 references indexed in Scilit:

• Gemcitabine Combined with Infusional 5-Fluorouracil and High-Dose Leucovorin for the Treatment of Advanced Carcinoma of the Pancreas
  Chemotherapy, 2004
• Phase II Study of Gemcitabine Combined with Uracil-Tegafur in Metastatic Pancreatic Cancer
  Oncology, 2004
• Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Groupphase II study
  Annals of Oncology, 2003
• Phase II Study of Gemcitabine, 5-Fluorouracil, and Leucovorin in Patients With Pancreatic Cancer
  Seminars in Oncology, 2001
• A phase II study: docetaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma
  European Journal Of Cancer, 2000
• A Phase II Study of Gemcitabine and 5-Fluorouracil in Metastatic Pancreatic Cancer: An Eastern Cooperative Oncology Group Study (E3296)
  Oncology, 2000
• A phase II trial of topotecan in patients with previously untreated pancreatic cancer
  Anti-Cancer Drugs, 1996
• Activity of cisplatin in adenocarcinoma of the pancreas
  European Journal Of Cancer, 1993
• A phase II study of epirubicin in patients with advanced adenocarcinoma of the pancreas
  European Journal Of Cancer, 1992
• Phase II study of epirubicin in advanced adenocarcinoma of the pancreas
  European Journal of Cancer and Clinical Oncology, 1985